Filing Details

Accession Number:
0001104659-21-055581
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-27 16:03:26
Reporting Period:
2021-04-26
Accepted Time:
2021-04-27 16:03:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1173281 Neubase Therapeutics Inc. NBSE Pharmaceutical Preparations (2834) 465622433
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1774588 A Dietrich Stephan C/O 350 Technology Drive, Fourth Floor
Pittsburgh PA 15219
President And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-26 12,000 $5.00 24,525 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,273,819 Indirect See footnote
Footnotes
  1. Shares held by Dietrich Stephan as a tenant by the entirety with his spouse.
  2. These shares are held in an irrevocable trust in which the spouse of the reporting person is the investment trustee, and the spouse and the descendants of the reporting person are its beneficiaries, and another irrevocable trust in which the reporting person is the investment trustee, and the reporting person and the descendants of the reporting person's spouse are its beneficiaries.